Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Number of items: 11.

White, P. Lewis, Posso, Raquel, Parr, Christian, Price, Jessica S., Finkelman, Malcolm and Barnes, Rosemary A. 2021. The presence of (1→3)-β-D-glucan as prognostic marker in patients after major abdominal surgery. Clinical Infectious Diseases 73 (7) , e1415-e1422. 10.1093/cid/ciaa1370

White, P. Lewis, Parr, Christian and Barnes, Rosemary A. 2018. Predicting invasive aspergillosis in haematology patients by combining clinical and genetic risk factors with early diagnostic biomarkers. Journal of Clinical Microbiology 56 (1) , e01122-17. 10.1128/JCM.01122-17
file

White, P., Parr, Christian, Thornton, C. and Barnes, Rosemary 2013. Evaluation of Real-Time PCR, Galactomannan Enzyme-Linked Immunosorbent Assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis. Journal of Clinical Microbiology 51 (5) , pp. 1510-1516. 10.1128/JCM.03189-12

Sanders, Andrew James ORCID: https://orcid.org/0000-0002-7997-5286, Parr, Christian, Davies, Gaynor, Martin, Tracey Amanda ORCID: https://orcid.org/0000-0003-2690-4908, Lane, Jane ORCID: https://orcid.org/0000-0002-1926-4909, Mason, Malcolm David ORCID: https://orcid.org/0000-0003-1505-2869 and Jiang, Wen Guo ORCID: https://orcid.org/0000-0002-3283-1111 2006. Genetic reduction of matriptase-1 expressionj is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo. Journal of Experimental Therapeautics and Oncology 6 (1) , pp. 39-48.

Sanders, Andrew James ORCID: https://orcid.org/0000-0002-7997-5286, Parr, Christian, Davies, Gaynor, Martin, Tracey Amanda ORCID: https://orcid.org/0000-0003-2690-4908, Lane, Jane ORCID: https://orcid.org/0000-0002-1926-4909, Mason, Malcolm David ORCID: https://orcid.org/0000-0003-1505-2869 and Jiang, Wen Guo ORCID: https://orcid.org/0000-0002-3283-1111 2006. Genetic reduction of matriptase-1 expression is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo. Journal of Experimental Therapeutics and Oncology 6 (1) , pp. 39-48.

Davies, Gaynor, Mason, Malcolm David ORCID: https://orcid.org/0000-0003-1505-2869, Martin, Tracey Amanda ORCID: https://orcid.org/0000-0003-2690-4908, Parr, Christian, Watkins, Gareth, Lane, Jane ORCID: https://orcid.org/0000-0002-1926-4909, Jiang, Wen Guo ORCID: https://orcid.org/0000-0002-3283-1111, Matsumoto, Kunio and Nakamura, Toshikazu 2003. The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesisin vivo. International Journal of Cancer 106 (3) , pp. 348-354. 10.1002/ijc.11220

Parr, Christian, Davies, G., Nakamura, T., Matsumoto, Kei, Mason, Malcolm David ORCID: https://orcid.org/0000-0003-1505-2869 and Jiang, Wen Guo ORCID: https://orcid.org/0000-0002-3283-1111 2001. The HGF/SF-induced phosphorylation of paxillin, matrix adhesion, and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variant. Biochemical and Biophysical Research Communications 285 (5) , pp. 1330-1337. 10.1006/bbrc.2001.5307

Parr, Christian and Jiang, Wen Guo ORCID: https://orcid.org/0000-0002-3283-1111 2001. Hepatocyte growth factor activators, inhibitors and antagonists and their implication in cancer intervention. Histology and Histopathology 16 (1) , pp. 251-268.

Parr, Christian, Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Nakamura, Toshikazu, Matumoto, Kunio and Jiang, Wen Guo ORCID: https://orcid.org/0000-0002-3283-1111 2000. NK4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells. International Journal of Cancer 85 (4) , pp. 563-570. 10.1002/(SICI)1097-0215(20000215)85:4<563::AID-IJC19>3.0.CO;2-D

Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Parr, Christian, Nakamura, Toshikazu, Matsumoto, Kunio, Jiang, Wen Guo ORCID: https://orcid.org/0000-0002-3283-1111 and Mansel, Robert Edward ORCID: https://orcid.org/0000-0002-8051-0726 2000. Inhibition of HGF/SF-induced breast cancer cell motility and invasion by the HGF/SF variant, NK4. British Journal of Cancer 59 (3) , pp. 245-254. 10.1023/A:1006348317841

Jiang, Wen Guo ORCID: https://orcid.org/0000-0002-3283-1111, Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Parr, Christian, Martin, Tracey Amanda ORCID: https://orcid.org/0000-0003-2690-4908, Matsumoto, Kunio, Nakamura, Toshikazu and Mansel, Robert Edward ORCID: https://orcid.org/0000-0002-8051-0726 1999. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. Clinical Cancer Research 5 (11) , pp. 3695-3703.

This list was generated on Tue Nov 29 03:47:34 2022 GMT.